Identifying Proteins as Markers in Neuroblastoma Cells Treated with Retinoic Acid
Author Information
Author(s): Mandili Giorgia, Marini Cristina, Carta Franco, Zanini Cristina, Prato Mauro, Khadjavi Amina, Turrini Franco, Giribaldi Giuliana
Primary Institution: Dipartimento di Genetica, Biologia e Biochimica, Università di Torino, Torino, Italy
Hypothesis
Can all-trans-retinoic acid treatment identify new differentiation markers in neuroblastoma cells?
Conclusion
The study found that differentially phosphorylated proteins may serve as better markers of differentiation in neuroblastoma than those that are merely differentially expressed.
Supporting Evidence
- Proteomic analysis identified two proteins significantly downregulated after 9 days of ATRA treatment.
- Phosphoproteomic analysis revealed 8 proteins that were differentially serine-phosphorylated and 3 that were differentially tyrosine-phosphorylated after ATRA treatment.
- All proteins were significantly regulated, indicating their potential as differentiation markers.
Takeaway
Researchers treated neuroblastoma cells with a substance called retinoic acid to see if it could help identify new markers that show how the cells are changing. They found some proteins that changed in a way that could help doctors understand the disease better.
Methodology
The study used mass spectrometry and a 2-DE approach to analyze the proteomic and phosphoproteomic patterns of neuroblastoma cells treated with all-trans-retinoic acid.
Limitations
The variability between different cell preparations may affect the results due to the tendency of neuroblastoma cells to undergo spontaneous differentiation in vitro.
Statistical Information
P-Value
p<0.05 for NDKA and p<0.01 for RCN1
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website